Literature DB >> 8389361

Comparison of the substrate-binding pockets of the Rous sarcoma virus and human immunodeficiency virus type 1 proteases.

C E Cameron1, B Grinde, P Jacques, J Jentoft, J Leis, A Wlodawer, I T Weber.   

Abstract

A steady state kinetic analysis of the avian myeloblastosis virus/Rous sarcoma virus (AMV/RSV) and human immunodeficiency virus Type 1 (HIV-1) retroviral proteases (PRs) was carried out using a series of 40 peptide substrates that are derivatives of the AMV/RSV nucleocapsid-PR cleavage site. These peptides contain single amino acid substitutions in each of the seven positions of the minimum length substrate required by the PR for specific and efficient cleavage. These peptide substrates are distinguished by the individual enzyme subsites of the AMV/RSV and HIV-1 PRs. The molecular basis for similarities and differences of the individual subsites for both proteases is discussed using steady state kinetic data and modeling based on crystal structures.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389361

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Inhibition and substrate recognition--a computational approach applied to HIV protease.

Authors:  H M Vinkers; M R de Jonge; E D Daeyaert; J Heeres; L M H Koymans; J H van Lenthe; P J Lewi; H Timmerman; P A J Janssen
Journal:  J Comput Aided Mol Des       Date:  2003-09       Impact factor: 3.686

2.  Altered Rous sarcoma virus Gag polyprotein processing and its effects on particle formation.

Authors:  Y Xiang; T W Ridky; N K Krishna; J Leis
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Analysis of cleavage site mutations between the NC and PR Gag domains of Rous sarcoma virus.

Authors:  G Schatz; I Pichova; V M Vogt
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

4.  Importance of the N terminus of rous sarcoma virus protease for structure and enzymatic function.

Authors:  G W Schatz; J Reinking; J Zippin; L K Nicholson; V M Vogt
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  Differential proteolytic processing leads to multiple forms of the CA protein in avian sarcoma and leukemia viruses.

Authors:  R B Pepinsky; I A Papayannopoulos; E P Chow; N K Krishna; R C Craven; V M Vogt
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

6.  An assembly domain of the Rous sarcoma virus Gag protein required late in budding.

Authors:  J W Wills; C E Cameron; C B Wilson; Y Xiang; R P Bennett; J Leis
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

7.  Amino acid preferences for a critical substrate binding subsite of retroviral proteases in type 1 cleavage sites.

Authors:  Péter Bagossi; Tamás Sperka; Anita Fehér; János Kádas; Gábor Zahuczky; Gabriella Miklóssy; Péter Boross; József Tözsér
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

8.  Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain.

Authors:  Y Xiang; C E Cameron; J W Wills; J Leis
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

9.  Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease.

Authors:  Steve C Pettit; Gavin J Henderson; Celia A Schiffer; Ronald Swanstrom
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Necessity of the spacer peptide between CA and NC in the Rous sarcoma virus gag protein.

Authors:  R C Craven; A E Leure-duPree; C R Erdie; C B Wilson; J W Wills
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.